drugset / Trial / NCT00832429

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

NCT00832429

NaSingle-groupOpen-labelDiagnostic

Summary

This phase II trial studies how well lymph node mapping works in finding disease that has spread from the place where it started to other places in the body in patients with sebaceous gland cancer of the eyelid. Lymph node mapping may help in planning surgery to remove cancer and affected lymph nodes.

Timeline

Start
2009-02-25
Primary completion
2024-08-27
Completion
2024-08-27

Drugs

EvaluationDrugModalityDoseRoute
Background Technetium Tc-99m Sulfur Colloid Diagnostic / imaging agent Other